Where Steris Stands With Analysts
Portfolio Pulse from Benzinga Insights
Steris (NYSE:STE) has been analyzed by 4 analysts in the last three months, with all ratings being somewhat bullish. The average 12-month price target is $263.75, reflecting a 0.96% increase from the previous target. Analysts have maintained or raised their ratings, indicating positive sentiment. Steris, a leader in sterilization services, has shown solid revenue growth but faces challenges in ROE and ROA compared to industry averages.
September 03, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Steris has received somewhat bullish ratings from analysts, with a 12-month price target of $263.75, indicating a positive outlook. The company's revenue growth is solid, but it faces challenges in ROE and ROA compared to industry averages.
All four analysts have given somewhat bullish ratings, and the average price target has increased, indicating positive sentiment. The company's solid revenue growth supports this outlook, although challenges in ROE and ROA may temper expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100